• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Group seeks greater diversity in clinical research

Group seeks greater diversity in clinical research

October 1, 2015
CenterWatch Staff

First of two parts

In 2006, a trial led to a “black box warning label” for an asthma medi­cation found to have a disproportion­ally increased death rate. It revealed that respiratory-related deaths oc­curred four times more often in Af­rican-Americans who took the drug.

In 2007, additional studies showed that long-acting beta-antagonist drugs worsen asthma due to down-regulation of b-adrenergic system as a result of the stimulation of b-recep­tors. This genotype affects roughly one-sixth of U.S. citizens and may be more prevalent in specific minorities, including African-Americans.

These studies are a classic example of why it is important all subgroups be appropriately represented in research.

Ensuring meaningful representa­tion of minorities in trials is a primary goal of the Consortium for Diversity in Clinical Research, which was orga­nized in 2011. CDCR is a group of ex­perienced sites, with a vested interest in increasing diversity in all aspects of clinical research trials, including Principal Investigators and subjects.

The sites represent 50 investigators collaborating on trials in multiple therapeutic areas. Sites are located in Florida, Georgia, Nebraska, Ten­nessee and Texas; they are minority-owned, have a minority principal in­vestigator or oversee a large database of minority subjects.

Historically, minorities have been underserved in clinical trials. His­panics represent 16% of the popula­tion but only 1% of U.S. clinical trial participants; African-Americans rep­resent 12% of the population but only 5% of participants.

The FDA Safety and Innovation Act passed by Congress in 2012 sup­ports efforts to enhance diversity of subgroups (sex, age, race and ethnic­ity). There is greater assurance in the safety and effectiveness of investiga­tional products when there is sub­group data to analyze.

Diversity at CDCR sites promotes representation of behavioral, cultural and genetic differences—therefore ensuring drugs are effective and safe for minority populations.

Next month: More on the CDCR’s mission.

 

Written by Guest Writer Melissa Poindexter. Poindexter, R.N., B.S.N., is president of Advances in Health (AIH), an independent clinical research center in Houston that specializes in women’s health. AIH has collaborated in phase I-IV trials since 1998. She is a member of the Consortium for Diversity in Clinical Research (CDCR), ACRP, DIA and SCRS.

This article was reprinted from Volume 22, Issue 10, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing